Supplementary Table 6 Cytogenetic findings in skin fibroblasts from patients with rheumatoid arthritis and osteoarthritis or unaffected normal controls
| Â | Karyotype/FISH | |
|---|---|---|
Subject/diagnosis | Passage 1 | Passage 4 |
EB20/RA | 46,XY; FISH: normal | 46,XY; FISH:+6 [6%];+12 [8%];incl. polyploid [2%] |
EB25/RA | 46,XX; FISH:+6 [6%];+9 [6%];incl. polyploid [1%] | n.a. |
EB26/RA | 46,XY; FISH: normal | n.a. |
EB27/RA | 46,XX; FISH: normal | n.a.; FISH: normal |
EB28/RA | 46,XY; FISH: normal | 46,XY |
EB9/OA | 46,XX; FISH:+7 [6%];+8 [7%] | n.a. |
EB10/OA | 46,XX: FISH:+7 [7%];+8 [7%] | 46,XX; FISH:+8 [9%];-18 [8%] |
EB11/OA | 46,XX; FISH:+18 [8%] | 46,XX; FISH: normal |
EB12/OA | 46,XX | 46,XX; FISH:+9 [6%]) |
EB13/OA | 46,XY; FISH: normal | n.a.; FISH:+4 [18%];+7 [17%];+9 [9%];+12 [10%];incl. polyploid [8%] |
EB14/OA | n.a. | 47,XX,+7[5]/46,XX[3]; FISH:+7 [5%];+8 [5%];+9 [6%];+X [8%];incl. polyploid [2%] |
EB15/OA | 46,XX; FISH:+7 [6%];+9 [6%];incl. polyploid [4%] | 47,XX,+7[2]; FISH:+6 [16%];+7 [45%];+8 [15%];+9 [23%];incl. polyploid [15%] |
EB16/OA | 46,XX; FISH:+6 [10%];+7 [10%];+8 [22%];+X [24%];incl. polyploid [8%] | n.a. |
EB17/OA | 46,XX; FISH: normal | 46,XX; FISH:+4 [10%];+6 [10%];+8 [11%];+12 [11%];incl. polyploid [9%] |
EB18/OA | 46,XX; FISH:+8 [5%] | 46,XX; FISH: normal |
EB19/OA | n.a.; FISH: normal | 46,XX; FISH:+7 [7%];+8 [7%];+9 [6%];+12 [10%];incl. polyploid [3%] |
EB21/OA | 46,XX; FISH: normal | 46,XX; FISH:+4 [5%];incl. polyploid [1%] |
EB22/OA | 46,XY; FISH: normal | 46,XY; FISH:+4 [11%];+6 [13%];+7 [12%];+9 [11%];incl. polyploid [10%] |
EB24/OA | n.a.; FISH:+4 [7%];+7 [7%];incl. polyploid [1%]. | 46,XX; FISH:+4 [23%];+6 [24%];+7 [22%];+9 [24%];incl. polyploid [22%] |
EB29/OA | n.a.; FISH: normal | n.a. |
J5/OA | n.a.; FISH:+4 [5%];incl. polyploid [3%] | n.a.; FISH:+4 [5%];+6 [7%];+7 [5%];+9 [7%];incl. polyploid [5%] |
LZ1/Nor | n.a.; FISH: normal | n.a. |
LZ2/Nor | 46,XX; FISH: normal | n.a. |
LZ3/Nor | 46,XY; FISH: normal | n.a. |
LZ5/Nor | 46,XY | n.a. |